Search News

Corporate Industry Technology Medical Updates

Mechanical Circulatory Support

Industry
TCT 2024 | NyokAssist® Makes Global Debut as a Novel Interventional Ventricular Assist Device 2024-11-01
Industry
magAssist Presents MoyoAssist® at ESAO 2024, Advancing Global Dialogue in Artificial Organ Technology 2024-09-26
Medical Updates
First Patient with NyokAssist™ Interventional Ventricular Assist Device: Dr. Junbo Ge's team successfully completed the first high-risk PCI treatment supported by the new generation of interventi 2023-08-23
Corporate
magAssist Attains Recognition as the Most Innovative Medical Device Product of 2023 2023-08-21
Corporate
magAssist's NyokAssist™ granted Designation by the FDA as a Breakthrough Device 2023-08-17
Corporate
BreathMo®: The New Generation ECMO system Revealed at ASAIO Conference 2023-07-22
Corporate
MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE 2023-06-17
Corporate
magAssist Gains Recognition for Its Innovation in the Cardiovascular Field at 2022 Critical Heart Disease Congress-International Society for Mechanical Circulatory Support Parallel Forum 2023-01-16
Technology
2022 Critical Heart Disease Congress (CHDC·2022) | “BreathMo® - An Ultra-portable ECMO System” by Dr. Chia Hao Hsu from magAssist Inc. 2023-01-06
Technology
Professor Nianguo Dong of Wuhan Union Hospital Gives Speech Entitled “Clinical Experience with the MoyoAssist® Extracorporeal Ventricular Assist Device” 2023-01-06

Tabs： membrane oxygenator, cardiac arrest, DonorLife Organ Care System, ECMO manufacturers, Fortune, left ventricular assist devices, multi-organ life support, Bridge-to-other destination therapy, Chronic heart failure, the new generation ECMO system,